Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures

dc.contributor.authorSánchez, Aránzazu
dc.contributor.authorÁlvarez Barrientos, Alberto
dc.contributor.authorBenito, Manuel
dc.contributor.authorFabregat Romero, Isabel
dc.date.accessioned2021-11-17T14:04:58Z
dc.date.available2021-11-17T14:04:58Z
dc.date.issued1996-03-29
dc.date.updated2021-11-17T14:04:58Z
dc.description.abstractTransforming growth factor-beta (TGF-beta), a growth regulator of fetal hepatocytes in primary culture, also regulates death of these cells. Dose-response analysis showed that the TGF-beta concentration needed to induce hepatocyte death (2.5 ng/ml) was 5 times that needed to inhibit growth in these cells (0.5 ng/ml). In response to TGF-beta, hepatocytes induced DNA fragmentation and the appearance of nuclei with a DNA content lower than 2C (diploid content), typical of a programmed cell death model. TGF-beta-induced apoptosis in fetal hepatocytes was preceded by an induction of reactive oxygen species production and a decrease in the glutathione intracellular content, indicating that this factor induces oxidative stress in fetal hepatocytes. Studies performed to analyze levels of c-fos mRNA, a gene whose expression is modulated by redox state, demonstrated that only high, apoptotic concentrations of TGF-beta (2.5 ng/ml) produced an increase in the mRNA levels of this gene, the level of induction being similar to that found when cells were incubated in the presence of tert-butyl hydroperoxide. Gel mobility shift assays showed that the c-fos-induced expression was coincident with an increase in AP-1 activity. Finally, cell death induced by TGF-beta in fetal hepatocytes was partially blocked by radical scavengers, which decreased the percentage of apoptotic cells, whereas these agents did not modify the growth-inhibitory effect elicited by TGF-beta in these cells. In summary, the results presented in this paper provide evidence for the involvement of an oxidative process in the apoptosis elicited by TGF-beta in fetal hepatocytes.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec579693
dc.identifier.issn0021-9258
dc.identifier.pmid8631767
dc.identifier.urihttps://hdl.handle.net/2445/181306
dc.language.isoeng
dc.publisherAmerican Society for Biochemistry and Molecular Biology
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1074/jbc.271.13.7416
dc.relation.ispartofJournal of Biological Chemistry, 1996, vol. 271, num. 13, p. 7416-7422
dc.relation.urihttps://doi.org/10.1074/jbc.271.13.7416
dc.rights(c) American Society for Biochemistry and Molecular Biology, 1996
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationApoptosi
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.classificationFetge
dc.subject.classificationMetabolisme
dc.subject.otherApoptosis
dc.subject.otherDrug side effects
dc.subject.otherLiver
dc.subject.otherMetabolism
dc.titleApoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
579693.pdf
Mida:
359.26 KB
Format:
Adobe Portable Document Format